Ayla Mapel
Dr. Ayla Mapel is an innovative researcher at the Shmunis School of Biomedicine and Cancer Research, focusing on the development of 'micro-factories' for controlling chemical reactions. She recently received her second ERC grant for a project that aims to improve the production of antibody-drug conjugates (ADCs) for targeted cancer therapies, utilizing engineered micro-reactors to enhance conjugation efficiency.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Israel | 1 | 9.00 | 0.11% | +0% | 9,216,900 | 10,287 | $400,000 | 446$ |
| Totals | 1 | 9,216,900 | 10,287 | $400,000 | 446$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Professor Ayla Mapel is recognized for her groundbreaking research on antibody-drug conjugates and has received an ERC grant for a new production method.
9